cell-free DNA
The company showed early data establishing a rheumatoid arthritis-specific expression signature and is enrolling patients into a larger study.
Liquid Biopsy Comparison Highlights Cell-Free RNA, Multiomic Approaches for Detecting Gastrointestinal Cancers
Researchers used a range of cell-free DNA or cell-free RNA analysis methods to detect possible blood plasma markers for colorectal or stomach cancer.
Liquid Biopsy Startup Aqtual Raises $16M in Series A Financing
The startup will analyze cell-free DNA to develop blood-based assays to guide treatment in chronic diseases and oncology, starting with rheumatoid arthritis.
Multimodal Cell-Free DNA Test May Help Detect Cancer Early in Li-Fraumeni Syndrome Patients
Researchers analyzed cfDNA from blood focusing on genomic, fragmentomic, and epigenomic features linked to cancer in individuals with germline TP53 mutations.
FDA Approves Foundation Medicine CDx Tests for Pfizer's Braftovi-Mektovi Combo in Lung Cancer
The FoundationOne CDx and FoundationOne Liquid CDx tests were approved to determine whether patients with metastatic non-small cell lung cancer may be eligible for treatment.